Guidelines for the Diagnosis and Treatment of Cholangiocarcinoma: Consensus Document

Overview

Journal Gut

Specialty Gastroenterology

Date 2002 Oct 12

PMID 12376491

Citations 216

Authors

S A Khan

B R Davidson

R Goldin

S P Pereira

W M C Rosenberg

S D Taylor-Robinson

A V Thillainayagam

H C Thomas

M R Thursz

H Wasan

Affiliations

Soon will be listed here.

Citing Articles

Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy applications in upper and lower gastrointestinal cancer, a review.

Drittone D, Schipilliti F, Arrivi G, Mazzuca F Oncol Rev. 2024; 18:1496141.

PMID: 39659741 PMC: 11628282. DOI: 10.3389/or.2024.1496141.

Application of imaging technology for the diagnosis of malignancy in the pancreaticobiliary duodenal junction (Review).

Yang W, Hu P, Zuo C Oncol Lett. 2024; 28(6):596.

PMID: 39430731 PMC: 11487531. DOI: 10.3892/ol.2024.14729.

Biliary stents for active materials and surface modification: Recent advances and future perspectives.

Li Y, Yuan K, Deng C, Tang H, Wang J, Dai X Bioact Mater. 2024; 42:587-612.

PMID: 39314863 PMC: 11417150. DOI: 10.1016/j.bioactmat.2024.08.031.

Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models.

Awasthi N, Darman L, Schwarz M, Schwarz R J Cell Mol Med. 2024; 28(17):e18585.

PMID: 39223878 PMC: 11369204. DOI: 10.1111/jcmm.18585.

Identification of Novel Cuproptosis-Related Genes Mediating the Prognosis and Immune Microenvironment in Cholangiocarcinoma.

Liu Q, Zhu J, Huang Z, Zhang X, Yang J Technol Cancer Res Treat. 2024; 23:15330338241239139.

PMID: 38613350 PMC: 11015765. DOI: 10.1177/15330338241239139.

References

Madariaga J, Iwatsuki S, Todo S, Lee R, Irish W, Starzl T . Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. 1998; 227(1):70-9. PMC: 1191175. DOI: 10.1097/00000658-199801000-00011. View

Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P . Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology. 2001; 33(5):1029-35. DOI: 10.1053/jhep.2001.23912. View

Ducreux M, Rougier P, Fandi A, Villing A, Fassone F, Fandi L . Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol. 1998; 9(6):653-6. DOI: 10.1023/a:1008241008379. View

Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Kondo S . Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 1998; 5(1):52-61. DOI: 10.1007/pl00009951. View

Iwatsuki S, Todo S, Marsh J, Madariaga J, Lee R, Dvorchik I . Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg. 1998; 187(4):358-64. PMC: 2991118. DOI: 10.1016/s1072-7515(98)00207-5. View

Hejna M, Pruckmayer M, Raderer M . The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer. 1998; 34(7):977-86. DOI: 10.1016/s0959-8049(97)10166-6. View

Hochwald S, BURKE E, Jarnagin W, Fong Y, Blumgart L . Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg. 1999; 134(3):261-6. DOI: 10.1001/archsurg.134.3.261. View

Hultcrantz R, Olsson R, Danielsson A, Jarnerot G, Loof L, Ryden B . A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol. 1999; 30(4):669-73. DOI: 10.1016/s0168-8278(99)80198-6. View

Stain S, Baer H, Dennison A, Blumgart L . Current management of hilar cholangiocarcinoma. Surg Gynecol Obstet. 1992; 175(6):579-88. View

10.

Magnuson T, Bender J, Duncan M, Ahrendt S, Harmon J, Regan F . Utility of magnetic resonance cholangiography in the evaluation of biliary obstruction. J Am Coll Surg. 1999; 189(1):63-71; discussion 71-2. DOI: 10.1016/s1072-7515(99)00082-4. View

11.

Chapman R . Risk factors for biliary tract carcinogenesis. Ann Oncol. 1999; 10 Suppl 4:308-11. View

12.

Taylor-Robinson S, Toledano M, Arora S, Keegan T, Hargreaves S, Beck A . Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut. 2001; 48(6):816-20. PMC: 1728314. DOI: 10.1136/gut.48.6.816. View

13.

YATES J, Chalmer B, McKegney F . Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980; 45(8):2220-4. DOI: 10.1002/1097-0142(19800415)45:8<2220::aid-cncr2820450835>3.0.co;2-q. View

14.

Suzuki M, Takahashi T, Ouchi K, Matsuno S . The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer. 1989; 64(3):658-66. DOI: 10.1002/1097-0142(19890801)64:3<658::aid-cncr2820640316>3.0.co;2-6. View

15.

Chang W, Kortan P, Haber G . Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc. 1998; 47(5):354-62. DOI: 10.1016/s0016-5107(98)70218-4. View

16.

De Palma G, Galloro G, Siciliano S, Iovino P, Catanzano C . Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001; 53(6):547-53. DOI: 10.1067/mge.2001.113381. View

17.

Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H . Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001; 233(3):385-92. PMC: 1421255. DOI: 10.1097/00000658-200103000-00013. View

18.

Stevens K, Smith S, Denley H, Pinder S, Evans A, Chan S . Is mammography of value in women with disseminated cancer of unknown origin?. Clin Oncol (R Coll Radiol). 1999; 11(2):90-2. DOI: 10.1053/clon.1999.9020. View

19.

Henson D, Albores-Saavedra J, Corle D . Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates. Cancer. 1992; 70(6):1498-501. DOI: 10.1002/1097-0142(19920915)70:6<1498::aid-cncr2820700609>3.0.co;2-c. View

20.

Bhuiya M, Nimura Y, Kamiya J, Kondo S, Fukata S, Hayakawa N . Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg. 1992; 215(4):344-9. PMC: 1242450. DOI: 10.1097/00000658-199204000-00007. View